Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Arrowhead Pharmaceuticals (ARWR) Income from Non-Controlling Interests: 2010-2025

Historic Income from Non-Controlling Interests for Arrowhead Pharmaceuticals (ARWR) over the last 7 years, with Sep 2025 value amounting to $39.9 million.

  • Arrowhead Pharmaceuticals' Income from Non-Controlling Interests rose 1519.91% to $39.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $31.7 million, marking a year-over-year increase of 411.23%. This contributed to the annual value of $31.7 million for FY2025, which is 411.23% up from last year.
  • According to the latest figures from Q3 2025, Arrowhead Pharmaceuticals' Income from Non-Controlling Interests is $39.9 million, which was up 1,268.89% from -$3.4 million recorded in Q2 2025.
  • Arrowhead Pharmaceuticals' 5-year Income from Non-Controlling Interests high stood at $39.9 million for Q3 2025, and its period low was -$3.4 million during Q2 2025.
  • Moreover, its 3-year median value for Income from Non-Controlling Interests was -$2.1 million (2024), whereas its average is $1.6 million.
  • In the last 5 years, Arrowhead Pharmaceuticals' Income from Non-Controlling Interests slumped by 416.87% in 2023 and then soared by 1,519.91% in 2025.
  • Over the past 4 years, Arrowhead Pharmaceuticals' Income from Non-Controlling Interests (Quarterly) stood at -$486,000 in 2022, then tumbled by 416.87% to -$2.5 million in 2023, then increased by 15.09% to -$2.1 million in 2024, then surged by 1,519.91% to $39.9 million in 2025.
  • Its Income from Non-Controlling Interests was $39.9 million in Q3 2025, compared to -$3.4 million in Q2 2025 and -$2.6 million in Q1 2025.